Moderna Teams With IBM to Explore AI, Quantum Computing in Vaccine Development
20 Abril 2023 - 9:42AM
Dow Jones News
By Dean Seal
Moderna Inc. and International Business Machines Corp. have
teamed up to explore the use of artificial intelligence and quantum
computing in the development of Moderna's mRNA vaccines.
The companies said Thursday that they have signed an agreement
for IBM to provide Moderna with access to its quantum computing
systems and assist in exploring the potential application of
quantum technologies in solving Moderna's scientific
challenges.
Moderna and IBM also plan to apply an AI foundation model,
called MoLFormer, that can predict a molecule's properties in the
hope of better understanding the characteristics of prospective
mRNA medicines.
Moderna said its goal is to use MoLFormer to optimize mRNA as
well as lipid nanoparticles that encapsulate and protect mRNA as it
travels through the body.
The companies said the combination of formulation discovery with
generative AI would design mRNA medicines with "optimal safety and
performance."
"We are aiming for breakthrough advances with quantum computing,
so we are investing now in building a quantum-ready workforce, to
be fully prepared to harness the power of this technology," Moderna
Chief Executive Stéphane Bancel said.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
April 20, 2023 08:27 ET (12:27 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Moderna (NASDAQ:MRNA)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Moderna (NASDAQ:MRNA)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024
